跳至主要内容
临床试验/NCT02026440
NCT02026440Unknown不适用

Collection and Testing of Human Oral Fluid Samples/VioOne OF Sample Collection Device

Avioq, Inc.1 个研究点 分布在 1 个国家目标入组 250 人开始时间: 2013年12月最近更新:
适应症

试验速览

阶段
不适用
发起方
Avioq, Inc.
入组人数
250
试验地点
1
主要终点
Presence of Nicotine in Collected Oral Fluid Samples

研究概览

简要总结

The VioOne Oral Fluid Sample Collection Device can be used to collect human oral fluid samples for detection of cotinine using an ELISA cotinine assay.

详细描述

The Study to evaluate the VioOne Oral Fluid Sample Collection Device (herein referred to as VioOne Device) will consist of several sub-studies as described below:

A. Recovery Study

This study will determine the percent recovery of cotinine spiked into the oral fluid of non-smokers collected with the VioOne Sample Collection Device.

  1. Sample collection

Oral fluid will be collected per the VioOne package insert from five individuals self-reported to be non-smokers. The samples collected will then be individually spiked with cotinine to concentrations of 0, 5, 10, 15 or 25ng/mL. Two sets of each concentration will be prepared. One set will be stored at 2-8°C prior to testing and one set will be shipped per routine shipping conditions and tested upon return. 2. Testing

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • healthy adults (aged 18 or older)

排除标准

  • individuals with significant health problems.

结局指标

主要结局

Presence of Nicotine in Collected Oral Fluid Samples

时间窗: Within one week of sample collection

ELISA assay in comparison with the Mass-spec method will be used to detect the presence of nicotine in the oral fluid samples collected with the VioOne collection device.

次要结局

未报告次要终点

研究者

发起方
Avioq, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验